Xeris Biopharma Holdings Inc
NASDAQ:XERS
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Price:
5.3
USD
0.19%
Market Closed
Market Cap:
$879.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Xeris Biopharma Holdings Inc
NASDAQ:XERS
|
US |
|
S
|
Shandong Polymer Biochemicals Co Ltd
SZSE:002476
|
CN |
|
C
|
Caravelle International Group
NASDAQ:CACO
|
SG |
|
MyState Ltd
ASX:MYS
|
AU |
|
Jaxsta Ltd
ASX:JXT
|
AU |
|
Sampo Oyj
OMXH:SAMPO
|
FI |
|
H
|
Hugo Boss AG
OTC:HUGPF
|
DE |
|
G
|
Guangdong LingXiao Pump Industry Co Ltd
SZSE:002884
|
CN |
|
Akbank TAS
IST:AKBNK.E
|
TR |
Relative Value
The Relative Value of one
XERS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.3 USD,
Xeris Biopharma Holdings Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XERS Relative Value
HIDDEN
Multiples Across Competitors
XERS Competitors Multiples
Xeris Biopharma Holdings Inc Competitors
Xeris Biopharma Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Xeris Biopharma Holdings Inc
NASDAQ:XERS
|
880.9m USD | 3 | 1 590.1 | 26.7 | 39.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.2 | 15.7 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
